3.0
Apr 28, 2014
Current employee, more than 5 years
Recommend
CEO approval
Business Outlook
Pros
Great idea. Orphan drugs to meet unmet needs of patients with rare diseases and humanitarian program.
Cons
No documented processes,acknowleged bad practices continue for 5+ years, management promoted based on years of service rather than merit, terrible work/life balance, stagnant career growth since Sanofi acquisition.